Literature DB >> 7972603

Resting EEG in first-episode schizophrenia patients, bipolar psychosis patients, and their first-degree relatives.

B A Clementz1, S R Sponheim, W G Iacono, M Beiser.   

Abstract

We evaluated the resting electroencephalogram (EEG) of 50 first-episode schizophrenia patients and 55 of their relatives, 31 first-episode bipolar patients and 35 of their relatives, and 113 nonpsychiatric subjects and 42 of their relatives. The frequency characteristics of the EEG showed moderate stability for a subgroup of these subjects (n = 106) who were tested twice, approximately 9 months apart. Both the schizophrenia and bipolar patients showed a generalized pattern of increased delta and theta and decreased alpha activity. The bipolar patients demonstrated additional right hemisphere activity that was not present among the schizophrenia patients and nonpsychiatric subjects, a finding consistent with hypotheses concerning nondominant hemisphere involvement in the regulation of elated mood. The schizophrenia patients' female relatives and/or relatives with affective disorders and the bipolar patients had significantly reduced peak alpha frequencies. This finding may be related to reduced information processing capacity among these subjects.

Entities:  

Mesh:

Year:  1994        PMID: 7972603     DOI: 10.1111/j.1469-8986.1994.tb01052.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  49 in total

1.  NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus.

Authors:  Yuchun Zhang; Takashi Yoshida; Donald B Katz; John E Lisman
Journal:  J Neurophysiol       Date:  2012-03-14       Impact factor: 2.714

Review 2.  The status of spectral EEG abnormality as a diagnostic test for schizophrenia.

Authors:  Nash N Boutros; Cynthia Arfken; Silvana Galderisi; Joshua Warrick; Garrett Pratt; William Iacono
Journal:  Schizophr Res       Date:  2007-12-21       Impact factor: 4.939

3.  Sustained versus transient brain responses in schizophrenia: the role of intrinsic neural activity.

Authors:  Lauren Ethridge; Stephan Moratti; Yuan Gao; Andreas Keil; Brett A Clementz
Journal:  Schizophr Res       Date:  2011-08-11       Impact factor: 4.939

4.  Frequency of alpha oscillation predicts individual differences in perceptual stability during binocular rivalry.

Authors:  Sucharit Katyal; Sheng He; Bin He; Stephen A Engel
Journal:  Hum Brain Mapp       Date:  2019-01-31       Impact factor: 5.038

Review 5.  The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia.

Authors:  Samuel M Cohen; Richard W Tsien; Donald C Goff; Michael M Halassa
Journal:  Schizophr Res       Date:  2015-01-09       Impact factor: 4.939

6.  Psychosis subgroups differ in intrinsic neural activity but not task-specific processing.

Authors:  Matthew E Hudgens-Haney; Lauren E Ethridge; Jennifer E McDowell; Sarah K Keedy; Godfrey D Pearlson; Carol A Tamminga; Matcheri S Keshavan; John A Sweeney; Brett A Clementz
Journal:  Schizophr Res       Date:  2017-08-24       Impact factor: 4.939

Review 7.  Electrophysiological endophenotypes in rodent models of schizophrenia and psychosis.

Authors:  Andrew M Rosen; Timothy Spellman; Joshua A Gordon
Journal:  Biol Psychiatry       Date:  2015-03-27       Impact factor: 13.382

8.  Resting state EEG power and coherence abnormalities in bipolar disorder and schizophrenia.

Authors:  Julia W Y Kam; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick; Colleen A Brenner
Journal:  J Psychiatr Res       Date:  2013-09-20       Impact factor: 4.791

9.  Genetic and disorder-specific aspects of resting state EEG abnormalities in schizophrenia.

Authors:  Noah C Venables; Edward M Bernat; Scott R Sponheim
Journal:  Schizophr Bull       Date:  2008-04-01       Impact factor: 9.306

10.  Brain's alpha activity is highly reduced in euthymic bipolar disorder patients.

Authors:  E Başar; B Güntekin; I Atagün; B Turp Gölbaşı; E Tülay; A Ozerdem
Journal:  Cogn Neurodyn       Date:  2011-09-01       Impact factor: 5.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.